Form 5 - Annual statement of changes in beneficial ownership of securities

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 5 - Annual statement of changes in beneficial ownership of securities

Glaukos (NYSE:GKOS)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Glaukos Charts.

Glaukos (NYSE:GKOS)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Glaukos Charts.

Glaukos Corporation News

Form 144 - Report of proposed sale of securities
Friday 14 February 2025 (2 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 12 February 2025 (3 days ago) • Edgar (US Regulatory)

Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
Thursday 23 January 2025 (3 weeks ago) • Business Wire

Form 8-K - Current report
Tuesday 14 January 2025 (1 month ago) • Edgar (US Regulatory)

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
Tuesday 14 January 2025 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 2 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
Monday 23 December 2024 (2 months ago) • Business Wire

More Glaukos Corporation News Articles

Elite Pharmaceuticals (QB)

Northwest Biotherapeutics (QB)

North Bay Resources (PK)

Anavex Life Sciences

Fannie Mae (QB)

Lightwave Logic

Rennova Health (CE)

Good Vibrations Shoes (PK)

Kraig Biocraft Laborator... (QB)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions